Morepen Laboratories share price is Up ▲ 12.78% on 22-Aug-2024. | 113.77m shares traded.
Its CMP is Rs 78.64 and MCap is approx : 4302 Crores.
The stock is up ▲ 34.6% in 7 days,
up ▲ 42.6% in 1 month
and up ▲ 46.1% in 2 months.
Please click image for Latest Daily data.
–
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.
Click Image for Data | Scroll down for Comments
About Morepen Laboratories :
Founded: 1984
Headquarters: New Delhi
Number of employees: 1,649 (2023)
Subsidiaries: Morepen Inc., Doctor Morepen Limited
Morepen Laboratories Limited is a pharmaceutical company that develops, manufactures, and sells generic drugs and formulations for domestic and international customers. The company’s products are available in a variety of formulations, including tablets, capsules, injections, ointments, syrups, and powders. Morepen Laboratories was founded in 1984 and has headquarters in New Delhi, Haryana.
Morepen Laboratories has several business segments, including: Active Pharmaceutical Ingredients (APIs), Home Health, Dr. Morepen OTC & Healthcare Products, and Finished Formulations.
Morepen Laboratories has several achievements, including:
USFDA approved manufacturing facility since 1998
Largest producer of Montelukast in the world
Over 90% market share of Generic Loratadine in the US Market
Morepen Laboratories’ finished formulations include:
Intebact Capsules
Intelicaps Lax
Rythmix Kid Drop
Rythmix Kid Syrup
Kompact Powder
Saltum
Acifix 3X Suspension
Morepen Laboratories’ home health products include:
Dr. Morepen 49W Room Air Purifier with HEPA Filter
Dr. Morepen VP06 Breathe Free Vaporizer
Dr. Morepen CN06 Compressor Nebulizer
Dr. Morepen ST03 Dual Head Stethoscope
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-
Please visit
To find any stock of Indian stock market, with every day % .
Only Data. Not Buy or Sell advice.
Please share to reach more people.